Anya Prince on Gene Therapy and Exacerbating Health Care Inequalities

Anya Prince, a legal scholar and thought leader in the field of genetic discrimination, will present a new paper at Monday’s Health Law Workshop that interrogates whether gene therapies will exacerbate inequalities in health care, as more treatments enter the market. “Gene Therapy’s Field of Dreams: If You Build It, Will We Pay?” focuses on some of the many issues raised by the prices of gene therapies.
Read More

Machine Learning in Medicine: Addressing Ethical Challenges

Machine learning in medicine is accelerating at an incredible rate, bringing a new era of ethical and regulatory challenges to the clinic.

In a new paper published in PLOS Medicine, Effy Vayena, Alessandro Blasimme, and I. Glenn Cohen spell out these ethical challenges and offer suggestions for how Institutional Review Boards (IRBs), medical practitioners, and developers can ethically deploy machine learning in medicine (MLm). Read More

What happens when a fertility clinic is responsible for destroying reproductive material?

A recent article in Marie Claire delved into the story of a Cleveland fertility clinic that lost 4,000 frozen eggs and embryos belonging to 950 patients and featured commentary by Bill of Health contributors. In the piece, “When Your Dreams of Motherhood Are Destroyed,” three Bill of Health/Petrie-Flom Center affiliates discussed some of the many legal challenges of this particular case, and others like it.

The story was reported by 

Read More

Development and Delivery of Drug Pricing Policy

We know that drug pricing is a critical issue across the globe.

The Petrie-Flom Center, along with Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, will host a conference featuring fresh ideas for solutions from patient advocates, industry insiders, academic thought leaders, and administration officials.

Join us to engage with panels and keynotes where speakers will lead novel, interdisciplinary discussions in an effort to better address current challenges both in the U.S. and globally.

Confirmed speakers include Ronald Piervincenzi (CEO of the United States Pharmacopeial Convention), Sean Dickson (of the Drug Spending Research Initiative at The Pew Charitable Trusts), Hannah Kettler (Senior Program Officer, Industry Leadership Engagement and Thinkubator Lead at the Bill & Melinda Gates Foundation), Joe GroganAssociate Director, Health Programs, Office of Management and Budget), and many more. 

For a full conference schedule and to register, please click here!  Read More